Literature DB >> 18365826

Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients.

Dong Joon Kim1, Dong Ik Kim, Joon Soo Byun, Jin Young Jung, Sang Hyun Suh, Eung Yeop Kim, Kyung-Yul Lee, Ji Hoe Heo.   

Abstract

BACKGROUND: Mechanical thrombolysis may effectively enhance the efficacy of thrombolysis for hyperacute ischemic stroke patients.
PURPOSE: To assess the feasibility and results of simple mechanical-based thrombolysis using microwire and microcatheter with adjuvant low-dose intraarterial (i.a.) urokinase (UK) for the treatment of hyperacute ischemic stroke.
MATERIAL AND METHODS: Nineteen consecutive patients with hyperacute proximal middle cerebral artery (MCA) occlusions treated by a standardized protocol using microwire and microcatheter for mechanical thrombus disruption with adjuvant i.a. UK were reviewed. Simple to-and-fro passages through the clot with the microwire and microcatheter followed by disruptions by a J- or pigtail-shaped wire tip with alternating small-dose injections of UK distal, within, and proximal to the clot were performed. The recanalization rates, post-thrombolysis hemorrhage, and clinical outcome (baseline and discharge National Institute of Health Stroke Scale [NIHSS], mortality, 3-month modified Rankin scale [mRS]) were evaluated.
RESULTS: Recanalization was achieved in 18 of 19 patients (94.7%). The mean UK dose was 375,789 IU (range 130,000-580,000 IU). Two patients (10.5%) developed symptomatic hemorrhage. One of the hemorrhages included a patient who developed subarachnoid hemorrhage. Mortality rate was 15.8% (n = 3). The median baseline NIHSS scores showed improvement from 17 to 10 at presentation and discharge, respectively. At three months, good outcome was noted in 11 of 19 patients (57.9%, mRS 0-2).
CONCLUSION: Simple mechanical-based thrombolysis using microwire and microcatheter with adjuvant low-dose i.a. UK is safe and effective in achieving recanalization with good long-term outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365826     DOI: 10.1080/02841850701819143

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

Review 1.  Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.

Authors:  Rais Reskiawan A Kadir; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2019-09-24       Impact factor: 5.046

2.  Recanalization following various endovascular modalities for treatment of anterior circulation acute ischemic strokes.

Authors:  Akram Shhadeh; Ankur Garg; Ameer E Hassan; Steven Hoover; Scott Saucedo; Baharra Hassansad; Oriana Cornett; Vahid Tohidi; Adnan I Qureshi; Jawad F Kirmani
Journal:  J Vasc Interv Neurol       Date:  2012-06

3.  Reperfusion rates following intra-arterial thrombolysis for acute ischemic stroke: the influence of the method for alteplase delivery.

Authors:  G A Christoforidis; A Slivka; Y Mohammad; C Karakasis; M Kontzialis; M Khadir
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-16       Impact factor: 3.825

4.  Multimodal therapy for patients with acute ischemic stroke : outcomes and related prognostic factors.

Authors:  Seung Young Jeong; Seung Soo Park; Eun-Jeong Koh; Jong Pil Eun; Ha Young Choi
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

5.  Evidence-based changes in devices and methods of endovascular recanalization therapy.

Authors:  Cheolkyu Jung; Bae Ju Kwon; Moon Hee Han
Journal:  Neurointervention       Date:  2012-08-17

6.  Intra-arterial thrombolysis using double devices: mechanicomechanical or chemicomechanical techniques.

Authors:  Hyun Park; Gyo Jun Hwang; Sung-Chul Jin; Jae Seung Bang; Chang Wan Oh; O-Ki Kwon
Journal:  J Korean Neurosurg Soc       Date:  2012-02-29

7.  The usefulness of compliant balloon for recanalization of acute ischemic stroke.

Authors:  Mun Soo Kang; Jae Hoon Kim; Hee In Kang; Byung Gwan Moon; Seung Jin Lee; Joo Seung Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.